Pain Medicine, Interventional Pain Medicine · Farmington, CT
NPI
1316935034
Since 2005
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11 South Rd, Suite 250
Farmington, CT, 06032
Phone (860) 674-0222
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
4,279 services
Medicare patients, 2024
416
Average age 70
Drug cost, 2024
$428K
4,878 prescriptions
Company payments, 2025
$1,799
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Boolbol was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 2,369 times for 159 patients. In total Robert J Boolbol billed 4,279 services in 43 codes, and Medicare paid $197K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,369 | 159 | $0.09 | $204 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 502 | 242 | $51.86 | $26K |
| 99213 Office E&M - Established | Office | 165 | 106 | $68.95 | $11K |
| 80307 Drug Tests | Office | 109 | 89 | $60.90 | $6,638 |
| 64493 Nerve Block Injection - Back | Office | 86 | 62 | $205.74 | $18K |
| 64483 Nerve Block Injection - Back | Office | 85 | 56 | $253.70 | $22K |
| 64494 Nerve Block Injection - Back | Office | 84 | 61 | $112.03 | $9,410 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 83 | 72 | $153.46 | $13K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 79 | 40 | $51.40 | $4,061 |
| 62370 Musculoskeletal | Office | 74 | 13 | $74.21 | $5,491 |
| J7999 Compounded drug, not otherwise classified | Office | 70 | 13 | $118.72 | $8,311 |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 52 | 29 | $0.27 | $14.11 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 50 | 45 | $39.89 | $1,995 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 44 | 37 | $527.21 | $23K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 43 | 36 | $303.60 | $13K |
By year: 2022 $265K for 5,354 services; 2023 $171K for 3,656 services; 2024 $197K for 4,279 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 109 | 89 | $60.90 | $6,638 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 83 | 72 | $153.46 | $13K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 26 | 23 | $112.14 | $2,916 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Boolbol prescribed most often to Medicare patients was Oxycodone Hcl, with 790 prescriptions and refills. In total Robert J Boolbol wrote 4,878 Medicare prescriptions that cost $428K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 790 | 790 | 299 | $14K |
| Cyclobenzaprine Hcl Generic | 432 | 440 | 176 | $44K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 394 | 394 | 173 | $10K |
| Lidocaine Generic | 385 | 390 | 178 | $28K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 298 | 298 | 138 | $8,245 |
| Gabapentin Generic | 270 | 311 | 114 | $4,879 |
| Celecoxib Generic | 211 | 217 | 93 | $5,273 |
| Tramadol Hcl Generic | 188 | 188 | 89 | $2,242 |
| Diazepam Generic | 146 | 146 | 71 | $638 |
| Morphine Sulfate Er Morphine Sulfate | 146 | 146 | 65 | $2,937 |
| Pregabalin Generic | 141 | 149 | 56 | $3,568 |
| Meloxicam Generic | 101 | 106 | 46 | $316 |
| Tizanidine Hcl Generic | 98 | 107 | 52 | $1,497 |
| Hydromorphone Hcl Generic | 82 | 82 | 34 | $853 |
| Diclofenac Sodium Generic | 75 | 75 | 46 | $3,121 |
Brand drugs: 359 claims; generic drugs: 4,519 claims; opioid claims: 2,179.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Boolbol $1,799 ($1,799 in general payments such as food, travel and fees) from 12 companies. The largest payer was Collegium Pharmaceutical, Inc. with $543.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 45 | $543 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 46 | $434 |
| Scilex Pharmaceuticals Inc. | 12 | $231 |
| Valinor Pharma, LLC | 7 | $143 |
| TerSera Therapeutics LLC | 3 | $94.45 |
| Axsome Therapeutics, Inc. AXSM | 3 | $87.88 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $72.2 |
| Lundbeck LLC | 2 | $53.34 |
| Abbvie Inc. ABBV | 2 | $44.99 |
| Pfizer Inc. PFE | 2 | $42.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.